<DOC>
	<DOCNO>NCT02398357</DOCNO>
	<brief_summary>To determine effect safety anticoagulation endoscopic therapy cirrhotic patient portal vein thrombosis explore whether decrease short-term rebleeding rate .</brief_summary>
	<brief_title>The Effect Anticoagulation After Endoscopic Therapy Cirrhotic Patients With Portal Vein Thrombosis</brief_title>
	<detailed_description>The treatment cirrhotic patient PVT ( portal vein thrombosis ) clearly recommended guideline . Several publish study confirm effect safety anticoagulation therapy cirrhotic patient PVT.The present study observation study small sample size low quality.We need high-quality research randomize control trial . This Zelen-designed randomized control trial . Patients randomly enter two group : anticoagulation group control group make sure wether fond group make decision . The recanalization rate complication analyze</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Age 1870 year old ; A clinical , radiological histologic diagnosis Liver cirrhosis portal hypertension ; Diagnosed Portal vein thrombosis ; Capable understand purpose risk study inform consent participate study ; Have undergone endoscopy prevent variceal rebleeding . Age &lt; 18 &gt; 70 year ; Portal vein thrombosis diagnose 6 month ; Patients sign acute PVT fever，abdominal pain intestinal obstruction，who treat immediately ; Pregnant nursing ; Hepatocellular carcinoma ; Severe cardiopulmonary disease concomitant renal insufficiency ; cavernous transformation portal vein ; Contradictions endoscopy ; Contradictions anticoagulation , : allergy LMWH warfarin , severe uncontrolled hypertension , history hemorrhagic cerebral vascular accident , recent peptic ulcer disease , bacterial endocarditis , ulcerative colitis，sustained platelet count &lt; 50 x103/uL ) ; Taking immunosuppressive agent ; Coagulation disorder liver disease relate ; Variceal bleed fail control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>Zelen-designed randomize control trial</keyword>
</DOC>